Meg Marshall
Equibles does not estimate personal net worth.
About Meg Marshall
Barinthus Biotherapeutics plc. reported in an 8-K filed July 26, 2023 that Meg Marshall retired as Chief Medical Officer, effective July 20, 2023. The proxy statement of Barinthus Biotherapeutics plc. reports total compensation of $922,055 for Meg Marshall in fiscal 2022, including a base salary of $462,676. Disclosed compensation is on record for 3 fiscal years.
“On July 20, 2023, Dr. Margaret Marshall notified Vaccitech plc (the "Company") of her intention to retire from her position as Chief Medical Officer of the Company, effective immediately.”
Affiliation history
-
Barinthus Biotherapeutics plc. (BRNS)
Proxy statement
Start not stated–2023-07-20
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Barinthus Biotherapeutics plc. (BRNS) | Chief Medical Officer | $462,676 | $922,055 |
| 2021 | Barinthus Biotherapeutics plc. (BRNS) | Chief Medical Officer | $382,400 | $3,177,632 |
| 2020 | Barinthus Biotherapeutics plc. (BRNS) | | $45,833 | $684,162 |